GlassScriptPhysician profile
Margi Shah
NPI 1255954442
$2,993.70
in general payments reported to CMS, 2019-2025
18 companies · $1,327 in 2025
The $1,327 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $62.55 · 2021: $267 · 2022: $253 · 2023: $236 · 2024: $849 · 2025: $1,327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,410.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,647.68 | 2024-2025 | Optilight |
| Alcon Vision LLC | $382.78 | 2021-2025 | Hydrus Microstent, Dailies Total1, Total30 |
| Abbvie INC. | $194.31 | 2022-2023 | Durysta |
| Tarsus Pharmaceuticals, INC. | $176.98 | 2024-2025 | Xdemvy |
| Rxsight INC | $147.14 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $137.21 | 2020-2021 | |
| Biotissue Holdings INC. | $103.45 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $40.75 | 2020-2021 | |
| Aerie Pharmaceuticals, INC. | $24.16 | 2021 | |
| Sun Pharmaceutical Industries INC. | $23.75 | 2020-2021 | |
| Astellas Pharma US INC | $20.49 | 2024 | Izervay |
| Bausch & Lomb Americas INC. | $16.00 | 2023 | Lotemax Sm |
| Mallinckrodt Hospital Products INC. | $14.43 | 2021 | |
| Coopervision INC. | $14.04 | 2025 | Myday Contact Lens |
| Allergan, INC. | $13.43 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $13.39 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.41 | 2021 | |
| Eyevance Pharmaceuticals LLC | $11.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margi Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.